hypertensive%20crisis
HYPERTENSIVE CRISIS
Hypertensive emergency is having severely elevated blood pressure (>180-220 mmHg/120-130 mmHg) that is complicated by progressive target end-organ damage of the central nervous system, heart, kidneys, or the gravid uterus.
There is no definite blood pressure threshold for the diagnosis of hypertensive emergency.
Most target end-organ damage happen with diastolic blood pressure of ≥130 mmHg.
Hypertensive urgency refers to patients with severely elevated blood pressure (>180/110-120 mmHg) but with little or no evidence of acute end-organ damage.
The clinical differentiation between hypertensive emergencies and urgencies is dependent on the presence of target end-organ damage rather than the level of blood pressure.
Drug Information

Indication: HTN.

Indication: HTN. Adjunct to digitalis &/or diuretic therapy in CHF.

Indication: CHD: Chronic stable angina pectoris; HTN.

Indication: Control of BP in peri-op HTN. CHF associated w/ acute MI. Angina pectoris unresponsive to recommended doses of...

Dosage: Essential HTN Initially 10-20 mg daily. Maintenance: 20 mg once daily. Max: 40 mg daily. Renovascular HTN Init

Indication: Angina pectoris, CHF.

Indication: Treatment & prophylaxis of angina pectoris & treatment of variant angina.

Indication: Severe HTN in pregnancy. Hypotensive anaesth. Hypertensive episodes following acute MI.

Indication: All grades of essential HTN. Renovascular HTN. All degrees of heart failure. Prevention of symptomatic heart f...

Dosage: Tab Mild, moderate or severe HTN & angina pectoris w/ coexisting HTN Initially 100 mg bd. Increase in dose

1  /  3
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
23 Sep 2018
Supplementation with n−3 or omega-3 fatty acids does not help prevent serious vascular events in diabetic patients without evidence of cardiovascular disease at baseline, according to a study.
Tristan Manalac, 04 Aug 2018
Omega-3 fatty acid (FA) supplements do not yield significant cardiovascular benefits, according to a recent meta-analysis, which shows no reduction in fatal or nonfatal coronary heart disease (CHD) or major vascular events following supplementation.
Roshini Claire Anthony, 15 Apr 2019

Long-term testosterone therapy in obese men with hypogonadism led to sustained weight loss and improvements in multiple anthropometric parameters, according to an observational study presented at ENDO 2019.

20 Oct 2018
Seated diastolic blood pressure (DBP) show statistically significant inverse cross-sectional associations with total testosterone and sex hormone-binding globulin (SHBG), and a significant positive association with dehydroepiandrosterone sulphate (DHEAS), suggests a recent study.